Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
202.60    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.40 (0.198%)
Market Cap: £1.32b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Trading Statement

16 Apr 2026 07:00

RNS Number : 6500A
Ashmore Group PLC
16 April 2026
 

Ashmore Group plc 16 April 2026

THIRD QUARTER ASSETS UNDER MANAGEMENT STATEMENT

Ashmore Group plc (Ashmore, the Group), the specialist Emerging Markets asset manager, announces the following update to its assets under management (AuM) in respect of the quarter ending 31 March 2026.

Assets under management

Investment theme

Actual31 December 2025

(US$ billion)

Estimated31 March 2026

(US$ billion)

- External debt

8.4

8.0

- Local currency

15.7

16.4

- Corporate debt

5.3

5.1

- Blended debt

12.5

10.5

Fixed income

41.9

40.0

Equities

8.8

8.8

Alternatives

1.8

1.9

Total

52.5

50.7

 

AuM decreased by US$1.8 billion (-3%) over the period, comprising negative investment performance of US$0.9 billion and net outflows of US$0.9 billion. Positive momentum from 2025, supported by macro fundamentals and an ongoing capital rotation into emerging markets, continued into the period but was interrupted by the broadening of the conflict in the Middle East at the end of February. This resulted in heightened global market volatility and a "wait and see" approach being adopted by some investors.

Subscription activity remained healthy relative to recent period averages, delivering a net inflow in both local currency and equities. However, an institutional redemption from the blended debt theme meant there was a net outflow from blended debt as well as a small net outflow from external debt.

Emerging markets indices were flat to down 3% over the quarter, with strong performance in January and February followed by weaker global markets in March. Active investment management is critical to navigating such periods of market volatility and Ashmore continues to deliver outperformance for clients across its equity and fixed income strategies. Compared with 31 December, the proportion of Group AuM outperforming benchmark indices is consistent in the near to mid-term and has improved over the longer term.

 

Mark Coombs, Chief Executive Officer, Ashmore Group plc, commented:

"Geopolitical events interrupted some of the macro tailwinds supporting emerging markets, but the reaction across most asset classes has so far been manageable and with limited price dislocations. In the near term, investors globally are taking a more measured stance until there is greater clarity in the outlook for the duration of the conflict and its implications for factors such as commodity prices, inflation, interest rates and currency trends.

"As ever, it is paramount to understand the rich diversity of emerging markets and therefore to manage portfolios actively to deliver investment performance. Ashmore's specialist approach and long history of investing in emerging markets, across different cycles and complex geopolitical and macro events, means it is well positioned to navigate the current environment.

"At the end of the period, Ashmore was delighted to announce the establishment of a strategic partnership with Japan Post Insurance Co., Ltd. This new strategic partnership builds on a strong existing relationship in order to capitalise on the growth opportunity across a broad range of attractive emerging market asset classes."

 

Notes

Local currency AuM includes US$8.9 billion of AuM managed in overlay/liquidity strategies (31 December 2025: US$8.5 billion).

 

For further information please contact:

Ashmore Group plc Paul Measday +44 (0)20 3077 6278Jordan Griffin +44 (0)20 3077 6385 ir@ashmoregroup.com

Cardew Group Tom Allison +44 (0)7789 998020Will Baldwin-Charles +44 (0)7834 524833 ashmore@cardewgroup.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFIDSRIELIR
Date   Source Headline
14th Aug 20185:16 pmRNSHolding(s) in Company
13th Jul 20187:00 amRNSTrading Statement
2nd Jul 20188:44 amRNSDirectorate Change
20th Apr 20184:30 pmRNSDirector/PDMR Shareholding
17th Apr 20187:00 amRNSTrading Statement
4th Apr 20184:32 pmRNSDirector/PDMR Shareholding
29th Mar 20184:00 pmRNSDirector/PDMR Shareholding
8th Feb 20187:00 amRNSHalf-year Report
16th Jan 20187:00 amRNSTrading Statement
6th Dec 20171:55 pmRNSDirectorate Change
5th Dec 201711:45 amRNSDirector/PDMR Shareholding
5th Dec 201710:57 amRNSDirector/PDMR Shareholding
20th Oct 20173:08 pmRNSResult of AGM
13th Oct 20174:49 pmRNSDirector/PDMR Shareholding
13th Oct 20177:00 amRNSTrading Statement
19th Sep 20172:11 pmRNSDirector/PDMR Shareholding
19th Sep 20172:07 pmRNSDirector/PDMR Shareholding
7th Sep 20177:00 amRNSFinal Results
14th Jul 20177:00 amRNSTrading Statement
16th Jun 20177:00 amRNSInvestor presentation
21st Apr 20174:30 pmRNSDirector/PDMR Shareholding
18th Apr 20177:00 amRNSTrading Statement
10th Apr 20175:19 pmRNSDirector/PDMR Shareholding
29th Mar 20179:23 amRNSHolding(s) in Company
28th Mar 20174:54 pmRNSDirector/PDMR Shareholding
9th Feb 20177:00 amRNSHalf-year Report
16th Jan 20177:00 amRNSTrading Statement
21st Oct 20163:57 pmRNSResult of AGM
14th Oct 20167:00 amRNSTrading Statement
21st Sep 20164:30 pmRNSDirector/PDMR Shareholding
21st Sep 20164:30 pmRNSDirector/PDMR Shareholding
6th Sep 20167:00 amRNSFinal Results
10th Aug 201610:45 amRNSHolding(s) in Company
14th Jul 20167:00 amRNSTrading Statement
18th May 201610:00 amRNSAppointment of joint corporate broker
20th Apr 20164:28 pmRNSHolding(s) in Company
19th Apr 20167:00 amRNSTrading Statement
15th Apr 20164:39 pmRNSHolding(s) in Company
4th Apr 20168:56 amRNSDirector/PDMR Shareholding
24th Mar 20165:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20168:21 amRNSHolding(s) in Company
11th Feb 20167:00 amRNSHalf Yearly Report
14th Jan 20167:00 amRNSTrading Statement
11th Dec 20155:30 pmRNSDirector/PDMR Shareholding
11th Dec 20155:28 pmRNSDirectorate Change
7th Dec 201510:13 amRNSDirector/PDMR Shareholding
13th Nov 20159:15 amRNSDirector/PDMR Shareholding
28th Oct 201511:56 amRNSForm 8.3 - Al Noor Hospitals Group PLC
28th Oct 201511:52 amRNSForm 8.3 - NMC Health plc
27th Oct 20154:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.